165 related articles for article (PubMed ID: 35331118)
21. Latent autoimmune diabetes in adults (LADA) should be less latent.
Fourlanos S; Dotta F; Greenbaum CJ; Palmer JP; Rolandsson O; Colman PG; Harrison LC
Diabetologia; 2005 Nov; 48(11):2206-12. PubMed ID: 16193284
[TBL] [Abstract][Full Text] [Related]
22. Diabetic ketoacidosis as first presentation of latent autoimmune diabetes in adults in a patient with hashitoxicosis as first presentation of Hashimoto's thyroiditis: a case report.
Xenou M; Zoupas I; Lygnos D; Fousteris E
J Med Case Rep; 2022 Aug; 16(1):297. PubMed ID: 35918735
[TBL] [Abstract][Full Text] [Related]
23. Common autoimmune biomarkers, thyroid hormonal abnormalities, and beta cells dysfunction in patients with latent autoimmune diabetes in adults with type II diabetes mellitus.
Yousefzadeh G; Gozashti M; Najafipour H; Gholamhosseinian NA; Bahramnejad A; Shokouhi M
Diabetes Metab Syndr; 2016; 10(1 Suppl 1):S52-5. PubMed ID: 27094870
[TBL] [Abstract][Full Text] [Related]
24. Metabolite Profiling of LADA Challenges the View of a Metabolically Distinct Subtype.
Al-Majdoub M; Ali A; Storm P; Rosengren AH; Groop L; Spégel P
Diabetes; 2017 Apr; 66(4):806-814. PubMed ID: 27913577
[TBL] [Abstract][Full Text] [Related]
25. Autoimmune diabetes in adults: lessons from the UKPDS.
Desai M; Clark A
Diabet Med; 2008 Aug; 25 Suppl 2():30-4. PubMed ID: 18717976
[TBL] [Abstract][Full Text] [Related]
26. Peripheral blood mononuclear cells of patients with latent autoimmune diabetes secrete higher levels of pro- & anti-inflammatory cytokines compared to those with type-1 diabetes mellitus following
Badal D; Kumar R; Paul M; Dayal D; Bhansali A; Bhadada SK; Kumar R; Sachdeva N
Indian J Med Res; 2017 Jun; 145(6):767-776. PubMed ID: 29067979
[TBL] [Abstract][Full Text] [Related]
27. Low-grade Inflammatory Marker Profile May Help to Differentiate Patients With LADA, Classic Adult-Onset Type 1 Diabetes, and Type 2 Diabetes.
Castelblanco E; Hernández M; Castelblanco A; Gratacòs M; Esquerda A; Molló À; Ramírez-Morros A; Real J; Franch-Nadal J; Fernández-Real JM; Mauricio D
Diabetes Care; 2018 Apr; 41(4):862-868. PubMed ID: 29358494
[TBL] [Abstract][Full Text] [Related]
28. Latent Autoimmune Diabetes in Adults: A Review of Clinically Relevant Issues.
Hernández M; Mauricio D
Adv Exp Med Biol; 2021; 1307():29-41. PubMed ID: 32424495
[TBL] [Abstract][Full Text] [Related]
29. Persons with latent autoimmune diabetes in adults express higher dipeptidyl peptidase-4 activity compared to persons with type 2 and type 1 diabetes.
Duvnjak L; Blaslov K; Vučić Lovrenčić M; Knežević Ćuća J
Diabetes Res Clin Pract; 2016 Nov; 121():119-126. PubMed ID: 27693949
[TBL] [Abstract][Full Text] [Related]
30. Similar genetic features and different islet cell autoantibody pattern of latent autoimmune diabetes in adults (LADA) compared with adult-onset type 1 diabetes with rapid progression.
Hosszúfalusi N; Vatay A; Rajczy K; Prohászka Z; Pozsonyi E; Horváth L; Grosz A; Gerõ L; Madácsy L; Romics L; Karádi I; Füst G; Pánczél P
Diabetes Care; 2003 Feb; 26(2):452-7. PubMed ID: 12547879
[TBL] [Abstract][Full Text] [Related]
31. Tetraspanin 7 autoantibodies predict progressive decline of beta cell function in individuals with LADA.
Shi X; Huang G; Wang Y; Liu Z; Deng C; Li X; Zheng P; Zhou Z
Diabetologia; 2019 Mar; 62(3):399-407. PubMed ID: 30594957
[TBL] [Abstract][Full Text] [Related]
32. Abnormal Neutrophil Transcriptional Signature May Predict Newly Diagnosed Latent Autoimmune Diabetes in Adults of South China.
Xing Y; Lin Q; Tong Y; Zhou W; Huang J; Wang Y; Huang G; Li Y; Xiang Z; Zhou Z; Li T; Xiao Y
Front Endocrinol (Lausanne); 2020; 11():581902. PubMed ID: 33391182
[TBL] [Abstract][Full Text] [Related]
33. [Type LADA diabetes--interrogation points].
Otto-Buczkowska E
Przegl Lek; 2013; 70(1):25-7. PubMed ID: 23789301
[TBL] [Abstract][Full Text] [Related]
34. Adult-onset autoimmune diabetes: comparative analysis of classical and latent presentation.
Fadiga L; Saraiva J; Catarino D; Frade J; Melo M; Paiva I
Diabetol Metab Syndr; 2020 Dec; 12(1):107. PubMed ID: 33292447
[TBL] [Abstract][Full Text] [Related]
35. Autoantibody profile and epitope mapping in latent autoimmune diabetes in adults.
Falorni A; Calcinaro F
Ann N Y Acad Sci; 2002 Apr; 958():99-106. PubMed ID: 12021088
[TBL] [Abstract][Full Text] [Related]
36. Effect of extract from Boswellia serrata gum resin on decrease of GAD65 autoantibodies in a patient with Latent Autoimmune Diabetes in Adults.
Franić Z; Franić Z; Vrkić N; Gabaj NN; Petek I
Altern Ther Health Med; 2020 Sep; 26(5):38-40. PubMed ID: 32663183
[TBL] [Abstract][Full Text] [Related]
37. LADA: A Type of Diabetes in its Own Right?
Grill V
Curr Diabetes Rev; 2019; 15(3):174-177. PubMed ID: 30009711
[TBL] [Abstract][Full Text] [Related]
38. A Global Perspective of Latent Autoimmune Diabetes in Adults.
Mishra R; Hodge KM; Cousminer DL; Leslie RD; Grant SFA
Trends Endocrinol Metab; 2018 Sep; 29(9):638-650. PubMed ID: 30041834
[TBL] [Abstract][Full Text] [Related]
39. Development and Validation of a Prevalence Model for Latent Autoimmune Diabetes in Adults (LADA) Among Patients First Diagnosed with Type 2 Diabetes Mellitus (T2DM).
Wang Z; Zhang J; Xu H; Chen L; Dove A
Med Sci Monit; 2021 Sep; 27():e932725. PubMed ID: 34521804
[TBL] [Abstract][Full Text] [Related]
40. Efficacy and safety of sitagliptin and insulin for latent autoimmune diabetes in adults: A systematic review and meta-analysis.
Lin T; Cai Y; Tang L; Lian Y; Liu M; Liu C
J Diabetes Investig; 2022 Sep; 13(9):1506-1519. PubMed ID: 35445591
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
